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Objectives: This study aims to quantify the expected years of life lost (EYLL) that 
could be saved if the original Healthy People (HP) 2020 target goal for reducing 
invasive colorectal cancer (CRC) was met. MethOds: A total of 232,208 patients 
diagnosed with invasive CRC in 2000–2011 were identified from the Surveillance, 
Epidemiology, and End Results (SEER) registries. The lifetime survival functions for 
the cancer cohort and age-/sex-matched reference population were generated using 
a semiparametric extrapolation method with annual US life tables from 2000-2011. 
The EYLL for CRC was calculated by subtracting the estimated life expectancy of 
CRC patients from that of the reference population. The total EYLL that could be 
prevented was calculated by subtracting the age-adjusted incidence of invasive CRC 
rate of the base year from that of the target year multiplied by the average EYLL per 
person and the 2020 population projections. Results: An individual diagnosed 
with invasive CRC was estimated to have an average life-expectancy of 10.1 years 
and 6.8 EYLL. If the HP 2020 target goal for invasive CRC was met, the nation could 
potentially save an estimated 154,848 EYLL. For men and women with an invasive 
CRC, estimated EYLL were 74,528 and 79,334, respectively. By race, reducing invasive 
CRC would result in a significantly greater benefit for both black men and women 
compared to white men and women with p< 0.05. The estimated EYLL was 7.4 and 
8.0 years for black men and women and 6.4 and 6.1 years for white men and women 
per person, respectively. cOnclusiOns: The potential life years saved by success-
fully meeting the HP 2020 target for invasive CRC rate would be substantial for the 
nation. The benefit in terms of life years saved per person would be greater among 
blacks relative to whites.
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Objectives: The objectives of the study were to compare the likelihood of prostate-
specific antigen (PSA) screening, the likelihood of prostate cancer diagnosis (in those 
who were PSA screened), and patient satisfaction (in those who received a prostate 
cancer diagnosis) in men covered by private vs. public insurance. MethOds: This 
was a retrospective cross-sectional study of U.S. men 40 to 85 years of age. A nation-
ally representative Medical Expenditure Panel Survey (MEPS) data on American 
households was utilized to identify all men by age and by insurance status for 
years 2002 to 2011. Results: Overall, 15202 men covered by any private insurance 
and 7409 men covered by any public insurance reported PSA screening within the 
last two years. Of these men, 751 covered by private insurance vs. 402 covered by 
public insurance received a diagnosis of prostate believed cancer within the last two 
years. In 2011, 102 men covered by private insurance vs. 59 men covered by public 
insurance reported a diagnosis of prostate cancer. In 2011, 77 men (or 75%) covered 
by private insurance vs. 28 men (or 47%) covered by public insurance reported they 
were covered by health insurance that paid for all part of the medical care, tests or 
cancer treatment, p= 0.058. Forty-seven men or (46%) covered by private insurance 
vs. 15 men (or 25%) covered by public insurance reported cancer will come back to 
them or get worse within the next ten years. cOnclusiOns: More men were likely 
to get PSA screened and diagnosed with prostate cancer if covered by private insur-
ance. More men covered by private insurance believed their insurance covered all 
the necessary prostate cancer care. However, more men covered by private insurance 
feared a relapse. The role of health insurance in cancer care trajectory and patient 
satisfaction with care needs further exploration.
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Objectives: Inadequate information is currently available about incidence and 
healthcare burden of cervical cancer among women enrolled in Medicaid. This 
study aimed to determine incidence of cervical cancer and associated healthcare 
resource utilization in a national managed care Medicaid population. MethOds: 
A case–control study design using the 2006–2008 Medicaid data from 38 states in 
the United States (US) was utilized. The study sample included women (≥ 18 years) 
with cervical cancer. A corresponding group of non–cancer controls was selected to 
determine the incremental healthcare burden of cervical cancer. Propensity scor-
ing technique was used to match cases and controls on a 1:2 ratio based on age, 
race, and geographic region. Inpatient (IP), outpatient (OT), and emergency room 
(ER) visits were calculated for cases and controls. Receipt of cervical cancer treat-
ment including radiation therapy, chemotherapy, and surgical procedures was also 
assessed. Descriptive analyses were conducted using SASv9.3. Results: The study 
sample comprised of 5,183 incident cases of cervical cancer and 10,366 non–cancer 
controls. Cases had significantly higher IP (0.42 vs. 0.21), OT (79.92 vs. 59.77), and ER 
(4.79 vs. 3.38) visits as compared to controls. Among cases, significantly higher IP 
visits were observed among women between 30 and 49 years of age. Black women 
had significantly greater IP visits (0.146) as compared to Whites (0.096) and other 
racial groups (0.143). Mean IP, OT and ER visits increased with stage of cervical 
cancer. Cervical colposcopy, conization, and radiation therapy were performed in 
34.52%, 28.00%, and 19.97% of the cases, respectively. cOnclusiOns: Despite being 
were systematically searched for comparative observational studies, randomised 
clinical trials and economic evaluations for periods up to October 2014. Studies 
comparing case management nurse intervention versus traditional care for can-
cer patients reporting outcomes of interest such as survival and quality of life, 
care management quality, hospital management were selected for further analy-
sis. Results: The search identified 1,899 publications for screening and 43 were 
selected for full text review, of which 20 publications were included and extracted. 
Majority of the studies were conducted in North America (N= 11). Sample size ranged 
between 100 and 1,200 patients. Only three studies reported survival data, among 
which only one study reported a significant higher survival for the intervention 
group. Eight studies reported outcomes related to quality of life and results were dif-
ferent depending on the population studied and scale used (i.e. EQ-5D, HUI3, EORTC-
QLQ-C30, FACT-G, FACT-C). Care management quality was assessed in five studies, 
reporting an overall better treatment management in the intervention group. Data 
relating hospital management was reported in 12 studies with various different 
results and four studies reported data related to costs, in which the type of costs, 
methodological aspects and results were very diverse. cOnclusiOns: Out of all 
the publications included, the overall conclusions of the authors show very diverse 
results regarding the impact of case management nurses on cancer patients. The 
heterogeneity of the results and the lack of outcomes on costs, especially in Europe 
compared to North America, demonstrate the need to conduct robust prospective 
studies and cost-analyses on case management nurses.
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Objectives: Based on an 13-years experience (1999-2012) in collecting and ana-
lyzing real-world data for the Italian Regulatory Agency, CINECA Interuniversity 
Consortium has developed an innovative Cloud-based IT platform for the 
entire management of Performance-based Risk Sharing arrangements among 
Pharmaceutical Companies and Payers/Regulatory Authorities. The system has 
been used for more than 70 innovative drugs from eleven registries: oncology, 
diabetes, neurology, orphan drugs, rheumatology and others. More than 500.000 
patients were registered by over 900 health structures (40.000 end-users) in a time-
frame of seven years. MethOds: Establish a unique and complete post-marketing 
safety surveillance and analysis system, used by Health Authorities (regional and 
national), Clinicians/Researchers and Payors which allows the management of 
performance-based risk-sharing arrangements (PBRSAs). The solution is designed 
to ensure proper data collection aimed to evaluate appropriateness , assess drug 
safety and estimate efficacy (automated procedures and calculations) in a real-
world context. Independently from the already existing solutions and organizational 
settings, the model allows to easily set-up ad-hoc procedures for data collections 
in any international context (multi-country and multi-language) supporting the 
implementation of PBRSAs for oncology (Payment by Results, Cost-Sharing and 
Risk-Sharing). Results: The platform is able to manage any value-based scheme 
agreed between manufacturers and payers and it also may support drug combina-
tions. By defining appropriate minimum datasets, with a limited effort, it is possible 
to involve all stakeholders obtaining systematic, homogeneous and high-quality 
data. Example of trastuzumab and trastuzumab+pertuzumab combination will be 
reported. cOnclusiOns: The introduction of an online integrated registry ensures 
the economic sustainability of innovative therapies and simplify their market 
access, while guaranteeing transparency of the whole process. It also ensures treat-
ment appropriateness, helps in monitoring drug consumption and related costs 
(better resources allocation), improves the real-time reporting of adverse events and 
allows the development of real-world datasets for scientific purposes.
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Objectives: Pakistan has very high maternal mortality ratio in South Asia. The 
high maternal mortality could be due to low prenatal care utilization and unsafe 
births. This analysis examines socioeconomic inequalities in prenatal care utiliza-
tion and investigates the association between the household economic status, other 
socio-demographic variables and prenatal care in Pakistan. MethOds: The study 
draws data from Pakistan Living Standards Measurement Survey (PLSM) conducted 
in both rural and urban areas of Pakistan in 2010-11. This analysis is based on 
4,177 married women of reproductive age i.e. 15-49 who gave birth during the past 
three years in Punjab and Sindh. Household economic status is measured using 
household annual consumption expenditures and households are categorized into 
quintiles. Results: There are regional disparities in prenatal care utilization in 
Pakistan. The proportion of women receiving prenatal care in rural areas is much 
lower than their urban fellows (65.3% vs. 83.6%). There is regional variation in seek-
ing prenatal care as well, as 83.1% in north Punjab, 77.9% in central Punjab and 
67.3% in south Punjab received prenatal care, whereas the proportion is 70.7% in 
southern Sindh and only 51.5% in north Sindh. The multivariate logistic regression 
results reveal that women of bottom three quintiles are significantly less likely to 
receive prenatal care compared to members of the highest quintile. Those residing 
in rural areas and in the north and south Sindh have a significant and negative 
association with receiving prenatal care compared to women residing in urban 
and central Punjab. cOnclusiOns: Public health programs focussing on improv-
ing the prenatal care utilization, particularly of poor women and those residing in 
rural areas need to be initiated. Low prenatal utilization could be associated with 
high health care cost. Interventions aiming at reduced health care cost for poor and 
rural women need to be initiated.
